A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ALX Oncology Inc.
ALX Oncology Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Aurigene Discovery Technologies Limited
Pheon Therapeutics
University of Pittsburgh
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Avera McKennan Hospital & University Health Center
Orano Med LLC
RasCal Therapeutics, Inc.
Fondazione del Piemonte per l'Oncologia
Xencor, Inc.
City of Hope Medical Center
University Hospital, Clermont-Ferrand
Washington University School of Medicine
A2 Biotherapeutics Inc.
Arvinas Inc.
National Institutes of Health Clinical Center (CC)
MBrace Therapeutics
Ulsan University Hospital
New Phase Ltd.
Revolution Medicines, Inc.
University of Colorado, Denver
Roswell Park Cancer Institute
University of Nebraska
EXoPERT
Var2 Pharmaceuticals
University Health Network, Toronto
Revolution Medicines, Inc.
Massive Bio, Inc.
University of Calgary
Chongqing Precision Biotech Co., Ltd
Stony Brook University
Washington University School of Medicine
A2 Biotherapeutics Inc.
Centre Hospitalier de Valence
Revolution Medicines, Inc.
University of Florida
GONGCHU Biotechnology Co., Ltd
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Gustave Roussy, Cancer Campus, Grand Paris
University of Arizona
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
Sichuan University